<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR76">
 <label>76.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Vandebosch</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Mogg</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Goeyvaerts</surname>
    <given-names>N</given-names>
   </name>
   <name>
    <surname>Truyers</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Greenwood</surname>
    <given-names>B</given-names>
   </name>
   <name>
    <surname>Watson-Jones</surname>
    <given-names>D</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Simulation-guided phase 3 trial design to evaluate vaccine effectiveness to prevent Ebola virus disease infection: statistical considerations, design rationale, and challenges</article-title>
  <source>Clin.</source>
  <year>2016</year>
  <volume>13</volume>
  <issue>1</issue>
  <fpage>57</fpage>
  <lpage>65</lpage>
 </element-citation>
</ref>
